Dr. Piggott is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4901 Forest Park Ave
Fl 6
Saint Louis, MO 63108Phone+1 314-362-3937Fax+1 314-362-3725
Education & Training
- Washington University/B-JH/SLCH ConsortiumResidency, Ophthalmology, 2012 - 2015
- University of MarylandResidency, Internal Medicine, 2011 - 2012
- Emory University School of MedicineClass of 2011
Certifications & Licensure
- MO State Medical License 2015 - 2025
- American Board of Ophthalmology Ophthalmology
Publications & Presentations
PubMed
- 2 citations15-Gene Expression Profile andas Integrated Prognostic Test for Uveal Melanoma: First Report of Collaborative Ocular Oncology Group Study No. 2 (COOG2.1).J William Harbour, Zelia M Correa, Amy C Schefler, Prithvi Mruthyunjaya, Miguel A Materin
Journal of Clinical Oncology. 2024-10-01 - Vitreous microparticles contain apoptotic signals suggesting a diabetic vitreopathy.Harris Sultan, Rithwick Rajagopal, Prabakar Kumar Rao, Kisha Deslee Piggott, Michael A Paley
International Journal of Ophthalmology. 2022-01-01 - 10 citationsOncogenic Gq/11 signaling acutely drives and chronically sustains metabolic reprogramming in uveal melanoma.Michael D Onken, Sarah E Noda, Kevin M Kaltenbronn, Cheryl Frankfater, Carol M Makepeace
The Journal of Biological Chemistry. 2022-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: